A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
K Furuse, K Kubota, M Kawahara, M Ogawara… - Lung cancer, 1994 - Elsevier
To evaluate the effectiveness of vinorelbine (NVB) in patients with non-small cell lung
cancer (NSCLC), a late Phase II study was conducted. A total of 80 patients with Stage III or …
cancer (NSCLC), a late Phase II study was conducted. A total of 80 patients with Stage III or …
[引用][C] A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
K FURUSE, K KUBOTA, M KAWAHARA… - Lung …, 1994 - pascal-francis.inist.fr
A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated
advanced non-small cell lung cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …
advanced non-small cell lung cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …
A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study …
K Furuse, K Kubota, M Kawahara… - Lung cancer …, 1994 - pubmed.ncbi.nlm.nih.gov
To evaluate the effectiveness of vinorelbine (NVB) in patients with non-small cell lung
cancer (NSCLC), a late Phase II study was conducted. A total of 80 patients with Stage III or …
cancer (NSCLC), a late Phase II study was conducted. A total of 80 patients with Stage III or …
A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study …
K Furuse, K Kubota, M Kawahara… - Lung Cancer …, 1994 - europepmc.org
To evaluate the effectiveness of vinorelbine (NVB) in patients with non-small cell lung
cancer (NSCLC), a late Phase II study was conducted. A total of 80 patients with Stage III or …
cancer (NSCLC), a late Phase II study was conducted. A total of 80 patients with Stage III or …
A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
K Furuse, K Kubota, M Kawahara, M Ogawara… - Lung …, 1994 - lungcancerjournal.info
To evaluate the effectiveness of vinorelbine (NVB) in patients with non-small cell lung
cancer (NSCLC), a late Phase II study was conducted. A total of 80 patients with Stage III or …
cancer (NSCLC), a late Phase II study was conducted. A total of 80 patients with Stage III or …